Rad AI builds generative AI software for radiology that automates impression generation, integrates with voice-recognition and EMR workflows, reduces dictation workload, and automates incidental-finding tracking and follow-up.
ABOUT RAD AI At Rad AI, we’re on a mission to transform healthcare with artificial intelligence. Founded by a radiologist, our AI-driven solutions are revolutionizing radiology—saving time, reducing burnout, and improving patient care. With one of the largest proprietary radiology report datasets in the world, our AI has helped uncover hundreds of new cancer diagnoses and reduced error rates in tens of millions of radiology reports by nearly 50%. Rad AI has secured over $140M in funding, including a recently oversubscribed Series C ($68M round) led by Transformation Capital, bringing our valuation to $528M. Our investors include Khosla Ventures, World Innovation Lab, Gradient Ventures, Cone Health Ventures, and others—all backing our mission to empower physicians with cutting-edge AI. Our latest advancements in generative AI are used by thousands of radiologists daily, supporting more than one-third of radiology groups and healthcare systems and nearly 50% of all medical imaging in the U.S. at partners including Cone Health, Jefferson Einstein Health, Geisinger, Guthrie Healthcare System, and Henry Ford Health. Recognized as one of the most promising healthcare AI companies by CB Insights and AuntMinnie https://www.radai.com/news/auntminnie-recognizes-rad-ai-omni-reporting-as-2023s-best-new-radiology-software, and ranked by Deloitte https://www2.deloitte.com/us/en/pages/technology-media-and-telecommunications/articles/fast500-winners.html as the 19th fastest-growing company in North America, we are building AI-powered solutions that make a real impact. Most recently, Rad AI was named to CNBC’s Disruptor 50 https://www.cnbc.com/2025/06/10/2025-cnbc-disruptor-50-see-the-full-list-of-companies.html list, highlighting the innovation and momentum behind our mission. If you’re ready to shape the future of healthcare, we’d love to have you on our team! We build AI that sits directly in the radiologist’s workflow: - Rad AI Impressions automatically drafts the impression section of reports in real time. - Rad AI Reporting is a full radiology reporting platform powered by GenAI. - Rad AI Continuity is our patient follow‑up coordination platform, identifying actionable findings in radiology reports and closing the loop between radiology and downstream care. Continuity is already delivering real clinical and financial impact for health systems, improving follow‑up completion rates and catching cancers and other serious conditions earlier. Now we need someone to turn this proven product into a scaled, standalone business inside Rad AI. WHY WE NEED YOU: Continuity has crossed the line from promising experiment to real business and we are looking to add a strong Head of Product to oversee a cross-functional team. It has established recurring revenue, a strong pipeline, lighthouse health system customers, and clear proof that it changes patient outcomes and hospital economics. But today, its future still depends on how well we can focus, prioritize, and execute. Without you, Continuity risks being “just another product line” inside a busy, fast‑growing company. Roadmaps get reshuffled. Implementations take longer than they should. Customers feel the friction of a team that’s splitting its attention. Most importantly, patients who should get follow‑up care never do. You change that trajectory. You treat Continuity like your own startup inside Rad AI — with a clear vision, dedicated team, and simple, rigorous operating model. You connect product, engineering, clinical, implementations, and go‑to‑market into a single, coherent business. You protect focus, make hard tradeoffs, and turn great technology into reliable, referenceable outcomes for some of the largest health systems in the country. If you do your job well, Continuity becomes the way health systems close the loop on radiology findings at scale — and a core pillar of Rad AI’s long‑term success. If we don’t hire you, we risk leaving that opportunity, and those patients, on the table. HERE’S WHAT YOU’LL BE DOING: You will operate as the General Manager and CEO‑like leader of the Continuity business within Rad AI. You own the vision, the number, the roadmap, and the day‑to‑day execution that connects them. You’ll design and run a startup‑within‑a‑startup: a focused, cross‑functional team with clear goals, decision rights, and accountability. You’ll be deeply embedded with customers and your team in equal measure. You translate health system realities into product decisions, turn engineering capacity into deployed solutions, and make sure implementations result in measurable clinical and financial outcomes. You’ll work closely with Rad AI’s executive team, but you won’t wait for permission to act — you’ll build the systems, team, and habits that let Continuity scale. In particular, you will: - Own Continuity as a business – set the strategy, define the operating model, and be accountable for growth, profitability, and impact. - Connect product, engineering, and clinical reality – ensure the roadmap reflects real customer needs, technical constraints, and implementation learnings. - Lead a high‑performing, cross‑functional team – bring together engineers, model developers, implementation specialists, and clinical experts under a shared mission and set of goals. - Drive customer outcomes at scale – work directly with health system leaders to deliver faster implementations, stronger adoption, and clear ROI in follow‑up care and downstream revenue. - Operate like a founder – step into whatever role is needed, from refining contracts to unblocking an integration, while keeping your eyes on the long‑term build. YOU’RE THE RIGHT PERSON FOR THIS ROLE IF: - You have owned and scaled a product or business line — from early traction to meaningful revenue — in healthcare or enterprise SaaS, with clear accountability for ARR, adoption, and outcomes. - You have deep experience operating as a GM, founder, or P&L owner, le